Pradžia › Mezotelioma › Koloradas
Mezotelioma klinikiniai tyrimai Koloradas
8 tyrimai dėl Mezotelioma ieško dalyvių vietose Koloradas.
Miestai Koloradas
Oficialus tyrimo tekstas (anglų kalba)
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- SCRI at HCA HealthONE, Denver
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- Sarah Cannon Research Institute at HealthONE, Denver
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT06566079Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Grand Valley Oncology, Grand Junction
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT05245500Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Denver
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-12 · NCT06756035A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- University of Colorado Cancer Center, Aurora
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT06362369A Study of NX-1607 in Adults With Advanced Malignancies
- University of Colorado School of Medicine, Aurora
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-09 · NCT05107674Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.